glp-1 nejm receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Julio Rosenstock, MD Co-Authored an

Summary of NICE guidance for GLP-1 receptor agonists and tirzepatide in adults NG28 (PDF)

PloS One (2013) 8(5):e63276

Early studies show these medications minimize pregnancy complications related to gestational diabetes and control blood sugar levels

GLP-1 and GIP are naturally occurring gut hormones that play a central role in regulating appetite, blood sugar, and fat metabolism

JM receives compensation as Associate Editor for the journal Nutrition Reviews, and has received within the last 3 years consulting compensation from Church and Dwight, Inc., a producer and seller of consumer goods including vitamin supplements

Authors: Manuel Serrano Published: May 2017 Targeted Apoptosis of Senescent Cells Restores, Tissue Homeostasis in Response to Chemotoxicity and Aging This study reviews the role of oxytocin in regulating various physiological processes, including eating behavior and metabolism